[(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[[5-(3-hydroxyprop-1-ynyl)-1-(4-sulfamoylphenyl)triazol-4-yl]methylsulfanyl]oxan-2-yl]methyl acetate

InChIKey	`FJPVNBVAUQVIBQ-CAKRBILKSA-N`
Compound Name	[(2R,3S,4S,5R,6S)-3,4,5-triacetyloxy-6-[[5-(3-hydroxyprop-1-ynyl)-1-(4-sulfamoylphenyl)triazol-4-yl]methylsulfanyl]oxan-2-yl]methyl acetate
Canonical SMILES	`CC(=O)OC[C@H]1O[C@@H](SCc2nnn(-c3ccc(S(N)(=O)=O)cc3)c2C#CCO)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.1
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
Q16790	CA9	Homo sapiens	Human	PF00194	7.0	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	6.7	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	6.7	pIC50	TTD_MultiTarget